# Context Therapeutics funding: rounds and investors

> Context Therapeutics has raised $100M across 1 round since 2024. Investors include Blackstone Group and Blue Owl. Every round with its source.

Source: https://millionrounds.com/company/context-therapeutics (Millionrounds; every figure on the page links to its filing or article)

United States · [Funded startup](https://millionrounds.com/companies)

# Who invested in *Context Therapeutics*

One round we have observed, with the 2 investors named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

Biotech

Funding summary Updated 26 Oct 2026

**$100M** raised across 1 round since 2024, from 1 source

- **Latest round:** Round, $100M May 2024
- **Investors:** 2

See who backed them

## The rounds

- **May 2024** Round **$100M** [Blackstone Group](https://millionrounds.com/fund/blackstone-group) [Blue Owl](https://millionrounds.com/fund/blue-owl) Source recorded SEC filing: $100M sold, first sale May 2024

## Founders and team

From Context Therapeutics's own website and the SEC filings it signed: 8 on the team.

- **Martin Albert Lehr** Chief Executive Officer
- **Andy Pasternak** Chairman, Independent Director
- **Erin Zebrowski** Director, Clinical Sciences
- **Jorie West** Senior Director of Program Management
- **Mary Sphar** Executive Assistant & Office Manager
- **Alex Albert Levit** Executive Officer i
- **Jennifer Albert Minai-Azary** Executive Officer i
- **Linda Beth West** Independent Director

On the board, as filed i *Jennifer Beth Evans Stacey* *Philip Jay Kantoff* *Richard Jay Berman*

## Everyone who backed them

[Blackstone Group](https://millionrounds.com/fund/blackstone-group) Private equity **1** round

[Blue Owl](https://millionrounds.com/fund/blue-owl) Asset manager **1** round

Missing a round, or an investor who was in one? [Tell us](https://millionrounds.com/corrections?slug=context-therapeutics).

## Also claim to have backed them

This firm lists Context Therapeutics as a portfolio company on their own website, but no report of a round names it. They are the firms' own claims, kept apart from the rounds above.

[Nextech Invest](https://millionrounds.com/fund/nextech-invest) Private equity Per its own site

## Quick answers about Context Therapeutics

### Who invested in Context Therapeutics?

Context Therapeutics's investors include Blackstone Group and Blue Owl.

### How much has Context Therapeutics raised?

Context Therapeutics has raised $100M across 1 round since 2024.

### When did Context Therapeutics last raise?

Context Therapeutics's most recent round was an Undisclosed round of $100M in May 2024.

### What was Context Therapeutics's biggest round?

Its most recent round, $100M in May 2024, is also its largest on record.

### Who backed Context Therapeutics first?

Context Therapeutics's first round on record, in May 2024, was backed by Blackstone Group and Blue Owl.

### What stage is Context Therapeutics at?

Context Therapeutics's latest named round is an Undisclosed round, in May 2024.

### Where is Context Therapeutics based?

Context Therapeutics is based in the United States.

## Companies like Context Therapeutics

In the same sector, and raised in the last eighteen months.

[**Star Therapeutics** $325M · Oct 2026](https://millionrounds.com/company/star-therapeutics)[**Promaxo** $106M · Oct 2026](https://millionrounds.com/company/promaxo)[**Prolific Machines** $105M · Oct 2026](https://millionrounds.com/company/prolific-machines)[**IMIO** $19M · Oct 2026](https://millionrounds.com/company/imio)[**Clinical Ink** $24M · Oct 2026](https://millionrounds.com/company/clinical-ink)[**Rejuvenate Bio** $13M · Oct 2026](https://millionrounds.com/company/rejuvenate-bio)

## Find investors like these

Search every investor by what they have actually funded, then narrow to your stage and market. Free.

Open the investor searchOr these rounds in the app